CureGenetics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
57
- Latest Deal Type
-
Series B2
- Latest Deal Amount
-
$9M
- Investors
-
7
CureGenetics General Information
Description
Developer of cell and gene therapy platforms designed to develop treatments for solid tumors and genetic diseases. The company's platforms offer CAR-NKT cell therapy development and AAV vector screening capabilities for targeted gene delivery and tumor treatment, enabling biotechnology and pharmaceutical companies to develop novel therapies for difficult-to-treat diseases.
Contact Information
Website
www.curegenetics.comCorporate Office
- Buildings B20 (1st-2nd floors) and C29 (Phase II) of the Biomedical Industrial Park
- Number 218 Sangtian Street
- Suzhou, Jiangsu 215000
- China
Corporate Office
- Buildings B20 (1st-2nd floors) and C29 (Phase II) of the Biomedical Industrial Park
- Number 218 Sangtian Street
- Suzhou, Jiangsu 215000
- China
CureGenetics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC (Series B2) | 28-Mar-2024 | $9M | Completed | Generating Revenue | ||
| 8. Secondary Transaction - Private | 20-Oct-2022 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B) | 01-Dec-2021 | Completed | Generating Revenue | |||
| 6. Early Stage VC | 12-Jan-2021 | Completed | Generating Revenue | |||
| 5. Early Stage VC (Series A2) | 23-Nov-2020 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series A1) | 19-Mar-2020 | Completed | Generating Revenue | |||
| 3. Secondary Transaction - Private | 09-Nov-2018 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 01-Mar-2018 | $17M | $19.1M | Completed | Generating Revenue | |
| 1. Seed Round | 22-Dec-2016 | $2.12M | $2.12M | Completed | Startup |
CureGenetics Comparisons
Industry
Financing
Details
CureGenetics Competitors (39)
One of CureGenetics’s 39 competitors is GMAX Bio, a Venture Capital-Backed company based in Hangzhou, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| GMAX Bio | Venture Capital-Backed | Hangzhou, China | ||||
| Adimab | Venture Capital-Backed | Lebanon, NH | ||||
| Mabworks Biotech | Venture Capital-Backed | Beijing, China | ||||
| CytomX Therapeutics | Formerly VC-backed | South San Francisco, CA | ||||
| Xenetic Biosciences | Corporation | Framingham, MA |
CureGenetics Patents
CureGenetics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4460512-A1 | Novel interleukin-2 polypeptides | Pending | 07-Jan-2022 | ||
| EP-4460512-A4 | Novel interleukin-2 polypeptides | Pending | 07-Jan-2022 | ||
| US-20250163117-A1 | Novel interleukin-2 polypeptides | Pending | 07-Jan-2022 | ||
| WO-2023131270-A1 | Novel interleukin-2 polypeptides | Inactive | 07-Jan-2022 | ||
| EP-4386010-A1 | Modified cell, and preparation method therefor and use thereof | Pending | 12-Aug-2021 | A61K40/11 |
CureGenetics Signals
CureGenetics Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Advantech Capital Partners | PE/Buyout | Minority | ||
| Blue Ocean Capital Group | Venture Capital | Minority | ||
| Ming Bioventures | Venture Capital | Minority | ||
| Suzhou Oriza Holdings Corporation | Asset Manager | Minority | ||
| Qiming Venture Partners | Venture Capital | Minority |
CureGenetics FAQs
-
When was CureGenetics founded?
CureGenetics was founded in 2016.
-
Where is CureGenetics headquartered?
CureGenetics is headquartered in Suzhou, China.
-
What is the size of CureGenetics?
CureGenetics has 57 total employees.
-
What industry is CureGenetics in?
CureGenetics’s primary industry is Discovery Tools (Healthcare).
-
Is CureGenetics a private or public company?
CureGenetics is a Private company.
-
What is CureGenetics’s current revenue?
The current revenue for CureGenetics is .
-
How much funding has CureGenetics raised over time?
CureGenetics has raised $125M.
-
Who are CureGenetics’s investors?
Advantech Capital Partners, Blue Ocean Capital Group, Ming Bioventures, Suzhou Oriza Holdings Corporation, and Qiming Venture Partners are 5 of 7 investors who have invested in CureGenetics.
-
Who are CureGenetics’s competitors?
GMAX Bio, Adimab, Mabworks Biotech, CytomX Therapeutics, and Xenetic Biosciences are some of the 39 competitors of CureGenetics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process